IN Brief:
- UKHSA has reinstated Kier’s existing preconstruction agreement for the H50 high-containment laboratory in Harlow.
- The facility is planned to provide CL3 and CL4 laboratories, including suited CL4 capability.
- The wider campus programme targets early works from 2028 and service by September 2038.
Kier has resumed preconstruction services for the H50 high-containment laboratory at the planned UK Health Security Campus in Harlow. The UK Health Security Agency (UKHSA) reactivated its existing Pre-Construction Services Agreement, a development confirmed on 26 October 2026. The renewed work covers the specialist H50 package, rather than a new award for the entire £3.52bn campus, and does not mean main construction of the building has started.
H50 is designed to provide laboratories for Containment Level 3 and Containment Level 4 pathogens. UKHSA’s programme case specifically identifies suited CL4 facilities, in which scientists use supplied-air protective clothing for certain work. This method places particular demands on secure transitions between areas, controlled air movement, robust services and safe decontamination. The laboratory building must therefore be designed and validated as an integrated containment environment, not merely fitted out as conventional laboratory space.
Kier’s original role in the Harlow programme dates back to an earlier procurement, and work was interrupted as the government reconsidered the future location and financing of UKHSA facilities. Restoring the agreement allows detailed design and preconstruction planning to continue under the revised campus programme. The change is contractually distinct from the broader decision to consolidate UKHSA operations at Harlow, which IN Site covered earlier in October.
The government programme business case describes a small domestic market for construction on this scale: it identifies three UK suppliers capable of delivering the specialist CL4 work. The agency estimated that replacing Kier through a fresh procurement would add 12–18 months and could disrupt its critical path. That figure is an official programme risk estimate, rather than an elapsed delay. Reinstating an experienced delivery team addresses procurement continuity, while leaving design assurance and the construction programme still to be completed.
H50 forms one principal package alongside a separate main building package, which will contain other laboratory grades, support accommodation and offices. Maintaining distinct packages allows the containment facility to be managed around its specialist requirements. It also creates interfaces requiring close coordination: site-wide roads, supplies, drainage, utility resilience, deliveries and commissioning activities will connect both buildings. Failures at those boundaries could affect laboratory readiness even where individual contractors have completed their own physical works.
Containment operation depends on controlled pressure relationships, airflow direction, filtration, physical barriers and monitored access arrangements working together. High-containment suites also require carefully planned maintenance routes and backup arrangements for critical plant. These functions must be demonstrated during testing and qualification, since performance depends on connections between building fabric, ducts, penetrations, sensors and controls. No detailed H50 airflow rates, equipment selections or pressure setpoints have been disclosed, and the technical design remains within the preconstruction phase.
The £3.52bn allocation relates to the overall campus through September 2038, rather than the value of Kier’s agreement. The published business case allocates approximately £3.022bn to capital and £503m to revenue expenditure and transition-related costs. UKHSA has not disclosed a separate construction contract sum for H50 in the reactivation announcement. The distinction between the programme envelope, the preconstruction services appointment and any eventual main works contract remains important as procurement progresses.
At Harlow, UKHSA plans to bring together specialist functions currently located at Porton Down, Colindale and its London headquarters. The programme anticipates transferring as many as possible of approximately 2,500 existing roles, with detailed staffing plans still in development. Laboratories cannot simply be occupied as soon as building work ends: containment systems, equipment and procedures require testing and operational validation, while critical scientific activity must continue elsewhere during the transition.
UKHSA’s current master schedule anticipates early works from 2028, main construction beginning in the fourth quarter of 2029, validation and dual running from the first quarter of 2034, and the campus entering service by September 2038. These dates describe the wider programme, not guaranteed handover points for each H50 work package. The time allowed for commissioning and overlapping operation reflects the need to establish laboratory performance before essential national services are transferred.
Kier expects to bring together its construction, engineering and mechanical and electrical capabilities during preconstruction. Detailed coordination between designers, construction specialists and UKHSA will now establish how the containment building connects to the other campus packages and the agency’s operational requirements. The immediate next steps concern design development, programme integration and assurance, with main works and laboratory validation still scheduled much further ahead.
